Aytu BioScience, Inc. (AYTU) has seen some recent action in the stock market and its shares were last quoted at $1.4500 yesterday. Investors are starting to take notice of AYTU as the shares traded as high as $1.4600 and as low as $1.4000 in the previous market day.

Aytu BioScience, Inc. (AYTU) average trading volume is 24.22M. However, in the previous market day Aytu BioScience, Inc. (AYTU) exchanged 6,303,791 shares. The 1st support level on AYTU is $1.43 and the 1st upside resistance level on AYTU is $2.10. AYTU 50 day moving average is $1.5494 and AYTU 200-day moving average is $1.0435.

Aytu BioScience, Inc. (AYTU) recent performance has been shown by the recent movement in AYTU shares. AYTU has performed -7.64% over the past 4 weeks, AYTU has performed 104.23% over the past quarter and AYTU has shown -36.12% over the past year. Aytu BioScience, Inc. (AYTU) has a 12 month range of $0.3400 to $2.9900. Aytu BioScience, Inc. (AYTU) is trading 332.58% from its 12 month low and -51.51% from its 12 month high. Aytu BioScience, Inc. (AYTU) is showing a 12.99% short float showing the amount short in the float.

AYTU has 59.63M shares outstanding and 54.55M shares in the float. Aytu BioScience, Inc. (AYTU) at this time has a market cap of $86.46M and income of $-24.20M. The EPS next quarter for AYTU is -0.22 and anticipated EPS net year is 91.90%. The market cap of Aytu BioScience, Inc. (AYTU) at $86.46M represents how many Investors own shares of AYTU and is calculated off the last price ($1.4500) of AYTU and the amount of shares outstanding (59.63M) with Aytu BioScience, Inc. (AYTU).

Aytu BioScience, Inc. (AYTU) has total cash (mrq) of 5.26M, total cash per share (mrq) of 0.23, total debt of AYTU is at 637.57k and total debt/equity (mrq) is 3.73. Aytu BioScience, Inc. (AYTU) running cash flow (ttm) is -15.87M and AYTU leveraged free cash flow (ttm) is -4.9M.

AYTU is trading -3.72% below (bearish) its SMA20, 7.31% above (bullish) its SMA50 and 26.87% above (bullish) its SMA200.

Recent News:

In recent news, on May 5, 2020, it was announced, SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aytu BioSciences, Inc. – AYTU. In this news it stated, Pomerantz LLP is investigating claims on behalf of investors of Aytu BioSciences, Inc. (“Aytu” or the “Company”) (NASDAQ: AYTU).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980.

About Aytu BioScience, Inc. (AYTU):

Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology. The company’s marketed products consists of ProstaScint(R), Primsol(R) and MiOXSYS(TM) which addresses prostate cancer, urinary tract infections, male infertility and male sexual dysfunction.